| 000 | 01840 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514195949.0 | ||
| 264 | 0 | _c20050316 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0948-6143 | ||
| 024 | 7 |
_a10.1007/s00418-004-0689-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKovacs, Werner J | |
| 245 | 0 | 0 |
_aThe hypolipidemic compound cetaben induces changes in Golgi morphology and vesicle movement. _h[electronic resource] |
| 260 |
_bHistochemistry and cell biology _cAug 2004 |
||
| 300 |
_a95-109 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a4-Aminobenzoic Acid _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCholesterol _xmetabolism |
| 650 | 0 | 4 |
_aCytoplasmic Vesicles _xdrug effects |
| 650 | 0 | 4 |
_aCytoskeleton _xdrug effects |
| 650 | 0 | 4 | _aElectrons |
| 650 | 0 | 4 |
_aEnzyme Precursors _xmetabolism |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
| 650 | 0 | 4 | _aFluorescent Dyes |
| 650 | 0 | 4 |
_aGolgi Apparatus _xdrug effects |
| 650 | 0 | 4 |
_aHomeostasis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLectins _xchemistry |
| 650 | 0 | 4 |
_aLipids _xbiosynthesis |
| 650 | 0 | 4 |
_aLovastatin _xpharmacology |
| 650 | 0 | 4 | _aMicroscopy, Electron |
| 650 | 0 | 4 |
_aMicrotubules _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _apara-Aminobenzoates |
| 700 | 1 | _aSchrader, Michael | |
| 700 | 1 | _aWalter, Ingrid | |
| 700 | 1 | _aStangl, Herbert | |
| 773 | 0 |
_tHistochemistry and cell biology _gvol. 122 _gno. 2 _gp. 95-109 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00418-004-0689-6 _zAvailable from publisher's website |
| 999 |
_c15020914 _d15020914 |
||